Is It Too Late to Buy Novavax Stock?
A few years ago, biotech company (NASDAQ: NVAX) looked like a promising stock. It emerged as a leader in the development of a COVID-19 vaccine, which sent its share price through the roof.
However, there have been a lot of negative developments for Novavax since then, and as a result, the biotech has given up all of its gains. Is there any hope for Novavax? If the company can improve its situation, investors who get in on the stock now could earn outsized returns.
Let's find out whether Novavax is likely to pull off a comeback or whether the best the company has to offer is in the rear-view mirror.
Source Fool.com
Novavax Inc. Stock
€7.32
6.710%
Our community is currently high on Novavax Inc. with 8 Buy predictions and 3 Sell predictions.
With a target price of 11 € there is a hugely positive potential of 50.27% for Novavax Inc. compared to the current price of 7.32 €.
